Stock report · Delisted · Nasdaq
Bionomics Ltd ADR (BNOX)
5.01USD Delisted Final close · Feb 24, 2025
BNOX no longer trades. Bionomics Ltd ADR was delisted from the Nasdaq in February 2025.
All prices on this page are historical. The last trade was on February 24, 2025, at $5.01.
BNOX stock price history
Final trading statistics
- Final close
- $5.01
- Final trading day
- Feb 24, 2025
- Market cap at delisting
- $8.15M
- Shares outstanding
- 1.63M
- Final 52-week range
- $0.18 – $12.55
- Avg. volume (final 3 mo.)
- 637,691
- All-time high
- $176.76 · Dec 2021
- All-time low
- $2.29 · Nov 2024
- Return since IPO
- -97.2%
- Beta
- -0.07
- Book value / share
- $1.32
- Price / book
- 3.80
About Bionomics Ltd ADR
Bionomics was an Australian clinical-stage biopharmaceutical company developing drugs for central nervous system disorders and cancer. Its lead candidate, BNC210, a selective negative allosteric modulator of the a7 receptor, was in Phase 3 for social anxiety disorder and Phase 2b for post-traumatic stress disorder.
Other programs included BNC101, an antibody aimed at cancer stem cells that had finished Phase 1, and BNC105, in Phase 2 for refractory colorectal cancer and Phase 1 for relapsed chronic lymphocytic leukemia. Preclinical work covered NextGen for CNS conditions, Kv3.1/3.2 agonists for cognitive and social symptoms in schizophrenia and autism, and Nav1.7/1.8 inhibitors for chronic pain without opioid-style addiction risk.
It worked with Merck & Co. on a7 positive allosteric modulators for cognitive problems in Alzheimer's disease and other CNS conditions. The company was incorporated in 1996 and based in Eastwood, Australia. Its ADRs were delisted from the Nasdaq in February 2025, with the final trade on February 24, 2025 at $5.01.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Eastwood, SA
- Employees
- 8
- IPO date
- December 16, 2021
- Delisted
- February 24, 2025
- SEC CIK
- 1191070
Bionomics Ltd ADR financials before the delisting
The last 5 fiscal years Bionomics Ltd ADR reported as a public company, fiscal year ending June.
BNOX revenue and net income
BNOX earnings per share
BNOX annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $20.0K | −$15.5B | — |
| FY2023 | $432.7K | −$21.2M | −$1.36 |
| FY2022 | $4.18M | −$15.0M | −$201.13 |
| FY2021 | $695.9K | −$6.5M | — |
| FY2020 | $2.07M | −$4.0M | −$0.00 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Bionomics Ltd ADR stock FAQ
What happened to Bionomics Ltd ADR stock?
Bionomics Ltd ADR was delisted from the Nasdaq in February 2025. The final close was $5.01 on February 24, 2025.
Can I still buy BNOX stock?
No. BNOX is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on February 24, 2025.
What was the last price of BNOX?
BNOX last closed at $5.01 on February 24, 2025, which valued the company at about $8.15M.
How did Bionomics Ltd ADR do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, Bionomics Ltd ADR reported revenue of $20.0K and net income of −$15.5B.
When did Bionomics Ltd ADR go public?
Bionomics Ltd ADR shares started trading on December 16, 2021.
BNOX no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.